MDBH MDB CAPITAL HOLDINGS LLC

New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups

New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups

Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk

Dallas, TX, May 14, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report on humanoid robotics. Titled the report uncovers a widening gap between escalating startup valuations and the lack of intellectual property (IP) protections underpinning them. Designed for investors, board members, and CEOs, it offers a strategic view into which companies are positioned to lead—and which are exposed—as capital floods into the humanoid robotics space.

“As capital floods into the space, investors and operators need a clear map of who owns what,” said Will Rosellini, Chief IP Officer at PatentVest. “IP is now a gating factor for scale, licensing, and long-term value capture.”

Key Insights

  • Strategic Leaders Are Emerging: While Figure AI commands attention and capital, Sanctuary AI is quietly building one of the most defensible platforms in the category. Other emerging leaders such as Neura Robotics, Apptronik, and Agility Robotics are gaining traction through focused IP strategies and execution-ready technologies.
  • Corporate IP Consolidation: More than 11,000 humanoid robotics patent families are held by industrial giants including Sony, UBTECH, Honda, Toyota, Hyundai, Alphabet, and Samsung. Among startups, only Sanctuary AI ranks among the global top 20 patent holders, showing just how rare defensible positions remain.
  • University-Led Innovation: Institutions such as Tsinghua University, AIST, Beijing Institute of Technology, KAIST, and the University of Tokyo hold key patents in locomotion, manipulation, and cognitive robotics. Their research continues to shape the core technologies and licensing opportunities that will drive the next wave of commercialization.

About the Report:

The analysis benchmarks the IP portfolios of leading startups—including Figure AI, Sanctuary AI, Apptronik, Tesla Optimus, Neura Robotics, Engineered Arts, 1X Technologies, and Collaborative Robotics—and maps 11,000+ patent families across 794 entities worldwide. It highlights where innovation is happening, who’s protecting it, and how defensible platforms are being built in one of the most capital-intensive, strategically complex technology sectors to emerge in decades.

                                                         

Access the Full Report

The PatentVest Pulse report is now available. Get the data, insights, and strategic intelligence behind the companies shaping the future of humanoid robots: .

For more information or inquiries, please contact .

About PatentVest

PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and expert analysis, PatentVest delivers actionable insights that help clients navigate complex IP landscapes and stay ahead of the curve. This report is powered by PatentVest’s proprietary IP intelligence platform.



EN
14/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent...

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report, “The Oral Small-Molecule GLP-1 Race: Beyond Orforglipron.” As injectable GLP-1 drugs built a $71 billion market while reaching less than 5% of eligible patients, fifty oral small-molecule programs are now racing to unlock the remainin...

 PRESS RELEASE

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service Addison, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today announced the appointment of Jeb Terry, Sr to its Board of Directors and extended its sincere gratitude to Susanne Meline as she concluded her dedicated and i...

 PRESS RELEASE

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trill...

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy New PatentVest Pulse analysis examines Elon Musk’s SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China’s growing influence Dallas, TX, Jan. 14, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the release of a new PatentVest Pulse report, The Patent Battlefield: How IP Portfolios Reveal the True Winners in the $1.8 Trillion Space Economy, a first-of-its-kind analysis using patent data to reveal who is positioned to win as the space sector goes mainstream. With Elon Musk’s SpaceX rumored ...

 PRESS RELEASE

MDB Capital Holdings Provides Third Quarter 2025 Update

MDB Capital Holdings Provides Third Quarter 2025 Update Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended September 30, 2025, and subsequent developments. Third Quarter 2025 and Subsequent Operational Highlights Anticipate closing two offerings shortly: This week: $16.8 million private placement offering for Paulex Bio, a biopharma...

 PRESS RELEASE

MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call...

MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time Addison, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Thursday November 20, 2025 at 4:30 p.m. Eastern Time to provide a business update for the third quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch